Skip Ribbon Commands
Skip to main content

Dr Thang Sue Ping

​MBChB (Edin), MRCP (UK)


Specialty: Nuclear Medicine and Molecular Imaging

Clinical Appointments

  • Consultant Nuclear Medicine and Molecular Imaging Singapore General HospitalSingapore General Hospital

Academic Appointments

  • Adjunct Assistant Professor
  • Clinical Physician Faculty Member, SingHealth Senior Residency Program
  • NYP Lecturer for radiographer studentds


​Dr Thang Sue Ping graduated from the University of Edinburgh in 2006. She obtained her Membership of the Royal College of Physicians, U.K in 2009. She started her Advanced Specialty Training in Nuclear Medicine at Singapore General Hospital in 2010 and completed training in March 2013. In 2016, she was awarded the HMDP fellowship from the Ministry of Health, Singapore and underwent further training at the Peter MacCallum Cancer Centre, Melbourne, Australia, with a special emphasis on theranostics and oncology imaging. She currently works as a Consultant at Singapore General Hospital.


  • ​Advanced Specialist Training in Nuclear Medicine (2010-2013)
  • Membership of the Royal College of Physicians, U.K. (MRCP (UK)) (2009)
  • Bachelor of Medicine, Bachelor of Surgery, University of Edinburgh, MBChB (Edin) (2001-2006)

Professional Appointments and Committee Memberships


  • ​Health Manpower Development Plan (HMDP) Award 2016
  • ACP Education Award (Residency) 2016
  • SGH Best Service Medical Officer (Internal Medicine) 2010

Publications and Research Trials

  1. Thang SP, Lung MS, Kong G, Hofman MS, Callahan J, Michael M, Hicks RJ. Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis. Eur J Nucl Med Mol Imaging. 2017 Sep 12. doi: 10.1007/s00259-017-3821-2.
  2. Huang HL, Dharmawan AR, Tan CJ, Thang SP. A rare case of thymoma first detected on gallium-68 PSMA PET/CT. Eur J Nucl Med Mol Imaging. 2017 Aug 1. doi: 10.1007/s00259-017-3785-2.
  3. Chow PK, Choo SP, Ng DC, Lo RH, Wang ML, Toh HC, Tai DW, Goh BK, Wong JS, Tay KH, Goh AS, Yan SX, Loke KS, Thang SP, Gogna A, Too CW, Irani FG, Leong S, Lim KH, Thng CH. National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma. Liver Cancer. 2016 Apr;5(2):97-106.
  4. Tan CJ, Thang SP, Lam WW. Unusual mediastinal lymph node uptake and peritoneopleural fistula demonstrated on Technetium-99m macro-aggregated human serum albumin (Tc-99m MAA) peritoneal scintigraphy in a patient with portal hypertension. Med J Malaysia. 2016 Apr;71(2):69-71.
  5. Rodríguez LS, Thang SP, Li H, Khor LK, Tay YS, Myint KO, Tong AK. A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications. Ann Nucl Med. 2016 Apr;30(3):255-61.
  6. Thang SP, Tong AK, Ng DC. Postmastectomy/Axillary Node Dissection Chyloma: The Additional Value of SPECT/CT Lymphoscintigraphy. J Breast Cancer. 2014 Sep;17(3):291-4.
  7. Thang SP, Tong AK, Lam WW, Ng DC. SPECT/CT in musculoskeletal infections. Semin Musculoskelet Radiol. 2014 Apr;18(2):194-202.
  8. Hsann YM, Thang SP, Abdul Salam ZH, Yang Y, Sui-Leong Lim V, Yang KS. Clinical characteristics and outcomes of hospitalized patients with 2009 H1N1 influenza in a large acute care tertiary hospital, Singapore. Am J Infect Control. 2011 Oct;39(8):e49-51.
  9. Thang SP, Tan AE, Goh AS. Bone Scan "Hot Spot" at the Superior Lateral Orbital Margin Fronto-zygomatic Suture Uptake Characterized with Tc-99m MDP SPECT/CT. World J Nucl Med. 2011 Jul;10(2):139-40.
  10. Tan AE, Thang SP, Padhy AK. Differentiating suspected nasopharyngeal infection from carcinoma using dual-tracer and multiple time-point technetium-99m sestamibi and white blood cell SPECT/CT imaging. Nucl Med Commun. 2011 May;32(5):416-8.

Research Trials